{"disease":{"id":"prostate-cancer-patients-treated-by-radiotherapy","name":"prostate cancer patients treated by radiotherapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07484971","title":"Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Société Algérienne de Formation et Recherche en Oncologie","has_results":false},{"nct_id":"NCT06970847","title":"64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Clarity Pharmaceuticals Ltd","has_results":false},{"nct_id":"NCT07126860","title":"The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Ludwig-Maximilians - University of Munich","has_results":false},{"nct_id":"NCT07325721","title":"Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT07130682","title":"Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Hong Kong Sanatorium & Hospital","has_results":false},{"nct_id":"NCT06653751","title":"Reminder App to Optimize Bladder Filling During Radiotherapy for Prostate Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"University Hospital Schleswig-Holstein","has_results":false},{"nct_id":"NCT06784115","title":"A Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated Radiotherapy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":27,"lead_sponsor_name":"University Hospital Schleswig-Holstein","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}